FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Nova Bio Recalls Glucose Meters

Nova Biomedical recalls its StatStrip Glucose and Glucose/Ketone Hospital Meters due to the potential risk that a software error may cause incorrect g...

latest-news-card-1
Human Drugs

Roche Sexual Disease Assay Panels Cleared

FDA clears a Roche 510(k) clearance for its cobas liat sexually transmitted infection multiplex assay panels.

latest-news-card-1
Human Drugs

Trial Speed Seen as Key to Accelerated Approvals

In an online post, three Hyman, Phelps attorneys say two new FDA guidances show how the agency plans to enforce its requirement that confirmatory tria...

latest-news-card-1
Human Drugs

Merck Stopping Winrevair Trial as Benefit Is Already Seen

Mercks ends the HYPERION trial of Winrevair early due to positive results from earlier trials so all participants can receive the drug.

latest-news-card-1
Human Drugs

Multiple Violations Cited at ProRx Outsourcing Facility

FDA warns Exton, PA-based ProRx about multiple violations in its production of drugs as an outsourcing facility.

latest-news-card-1
Medical Devices

Cybersecurity Vulnerabilities in 2 Patient Monitors

An FDA safety communication warns about cybersecurity vulnerabilities in Contec and Epsimed patient monitors.

latest-news-card-1
FDA General

Committee Chair Struggles to Support Kennedy

Senate Health Education Labor & Pensions Committee chair Bill Cassidy (R-LA) says he is having a difficult time believing HHS secretary-nominee Robert...

latest-news-card-1
Human Drugs

FDA Approves Axsomes Migraine Drug

FDA approves Axsome Therapeutics Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

latest-news-card-1
Human Drugs

FDA Clears Roche Lipoprotein (a) Assay

FDA clears a Roche 510(k) for its Tina-quant Lipoprotein (a) Gen.2 Molarity assay that measures lipoprotein (a) in nanomoles per liter.

latest-news-card-1
Medical Devices

Breakthrough Status for Meniscus Knee Implant

FDA grants OrthoPreserve a breakthrough device designation for its Defender meniscus replacement knee implant.